Professionals 91 results
Capabilities 28 results
Industry
Industry
Practice Area
Experience 5 results
Experience
|April 23, 2025
Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination
Experience
|January 29, 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Experience
|December 20, 2021
ACON Investments' Acquisition of Vitalis Group
Insights & News 393 results
Client Alert
|October 16, 2025
|5 Min Read
OIG Issues Advisory Opinion on Contributions to Charitable Foundations for Therapy Services
On September 11, 2025, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a favorable advisory opinion (AO 25-10 or the Opinion) regarding an arrangement between a healthcare services company (the Company) and a charitable foundation (the Foundation), whereby the Company makes financial contributions to the Foundation, which then provides grants to families of children receiving a particular type of therapy (the Arrangement). Pursuant to AO 25-10, the OIG will not impose sanctions with respect to the Arrangement, despite the Arrangement potentially generating prohibited remuneration under the federal Anti-Kickback Statute (the AKS) and implicating the civil monetary penalty provision prohibiting inducements to beneficiaries (the Beneficiary Inducements CMP).
Direct Sellers Update: Regulation, Law & Policy
|September 30, 2025
|5 Min Read
Are Your Electronic Agreements Enforceable?
In today’s digital marketplace, direct sellers rely heavily on electronic agreements to govern their relationships with customers, vendors, and partners. But whether these electronic agreements are enforceable depends, at least in part, on how your policies and other terms are presented to users and the way assent is obtained. Courts scrutinize these issues closely, emphasizing that even minor design choices can make the difference between a binding electronic agreement and an unenforceable set of terms.
Global Trade & Foreign Policy Insights
|September 26, 2025
|3 Min Read
USMCA at a Crossroads: Stakeholders Invited to Shape the Future
The Office of the United States Trade Representative (USTR) has initiated a public consultation process in preparation for the upcoming joint review of the United States–Mexico–Canada Agreement (USMCA), scheduled for July 1, 2026. This process is mandated by Article 34.7 of the USMCA and section 611 of the USMCA Implementation Act, which require a comprehensive evaluation of the agreement’s operation and a determination by each party on whether to extend the agreement for an additional 16-year term.
Other Results 35 results
Law Glossary
Law Glossary
What Is the Approval Process for Generic Drugs?
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?


